Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0000947871-11-000246
Filing Date
2011-03-11
Accepted
2011-03-11 17:27:33
Documents
1
Effectiveness Date
2011-03-11
Items
Item 06: Rule 506
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 13238
  Complete submission text file 0000947871-11-000246.txt   14442
Mailing Address C/O ORBIMED ADVISORS LLC 767 THIRD AVENUE, 30TH FLOOR NEW YORK NY 10017
Business Address C/O ORBIMED ADVISORS LLC 767 THIRD AVENUE, 30TH FLOOR NEW YORK NY 10017 212-739-6400
Caduceus Capital II, L.P. (Filer) CIK: 0001324240 (see all company filings)

EIN.: 134012775 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-128771 | Film No.: 11683264